12 Health Care Stocks Moving In Friday's After-Market Session

Author: Benzinga Insights | August 11, 2023 05:31pm

Gainers

• NuCana (NASDAQ:NCNA) stock rose 17.3% to $0.84 during Friday's after-market session. This security traded at a volume of 164.1K shares come close, making up 395.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $44.0 million.
• Neuronetics (NASDAQ:STIM) stock rose 10.22% to $1.94. The market value of their outstanding shares is at $56.0 million. As per the press release, Q2 earnings came out 3 days ago.
• AIM ImmunoTech (AMEX:AIM) stock rose 9.49% to $0.64. The company's market cap stands at $30.9 million.
• Baudax Bio (NASDAQ:BXRX) shares moved upwards by 8.38% to $0.63. The market value of their outstanding shares is at $4.5 million.
• Nemaura Medical (NASDAQ:NMRD) stock increased by 8.1% to $0.88. The market value of their outstanding shares is at $25.4 million.
• Virax Biolabs Group (NASDAQ:VRAX) shares rose 8.1% to $0.4. The market value of their outstanding shares is at $7.1 million.

Losers

• PHAXIAM Therapeutics (NASDAQ:PHXM) stock declined by 8.9% to $0.51 during Friday's after-market session. At the close, PHAXIAM Therapeutics's trading volume reached 67.5K shares. This is 30.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $31.1 million.
• Synlogic (NASDAQ:SYBX) stock decreased by 8.3% to $0.49. The company's market cap stands at $33.0 million. As per the press release, Q2 earnings came out yesterday.
• Aveanna Healthcare Hldgs (NASDAQ:AVAH) stock decreased by 8.16% to $1.69. The company's market cap stands at $314.1 million. The company's, Q2 earnings came out yesterday.
• Syros Pharmaceuticals (NASDAQ:SYRS) shares decreased by 8.12% to $3.51. The market value of their outstanding shares is at $72.6 million. As per the press release, Q2 earnings came out 3 days ago.
• China Pharma Holding (AMEX:CPHI) shares fell 7.21% to $0.23. The company's market cap stands at $2.2 million.
• SAB Biotherapeutics (NASDAQ:SABS) stock fell 5.43% to $0.76. The market value of their outstanding shares is at $39.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AIM AVAH BXRX CPHI NCNA NMRD PHXM SABS STIM SYBX SYRS VRAX